Opus Genetics, Inc.
IRDNasdaqCIK 1228627HealthcareFiscal year ends Dec 31
All transactions: 5
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-23 | Schachle Joseph KChief Operating Officer, Officer | Sale | 4,767 | $3.565 | $17.0k | Form 4 |
| 2026-10-23 | Yerxa Benjamin RPresident, Director, Officer | Sale | 25,520 | $3.5317 | $90.1k | Form 4 |
| 2026-10-23 | Yerxa Benjamin RPresident, Director, Officer | Sale | 7,669 | $3.5514 | $27.2k | Form 4 |
| 2026-10-23 | Gagnon Robert E.Chief Financial Officer, Officer | Sale | 14,000 | $3.5464 | $49.6k | Form 4 |
| 2026-10-23 | Magrath GeorgeChief Executive Officer, Director, Officer | Sale | 9,591 | $3.585 | $34.4k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 27, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.